Skip to main content
SpringerLink
Log in
Book cover

Family Medicine pp 1087–1094Cite as

Osteoporosis

  • Chapter

  • 43 Accesses

Abstract

Osteoporosis is a condition of reduced bone density and increased susceptibility to fractures without abnormal mineralization of bone matrix.1 The World Health Organization (WHO) defines osteoporosis as the presence of a bone mineral density (BMD) at least 2.5 standard deviations below the mean BMD for young adults.2 Osteoporosis affects an estimated 20 million to 25 million people in the United States, particularly postmenopausal women and the elderly of both sexes.3 Its most common serious manifestations are fractures of the hip, forearm, and vertebrae. Measures taken at several critical periods during the life cycle, especially childhood, the climacteric, and old age, have the potential to prevent osteoporotic fractures. Therefore family physicians are in a key position for preventing and treating this disease.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Consensus Development Conference. Prophylaxis and treatment of osteoporosis. Am J Med 1991;90:107–10.

    Article  Google Scholar 

  2. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. WHO Techn Rep Ser 1994;No. 843:1–6.

    Google Scholar 

  3. Nevitt MC. Epidemiology of osteoporosis. Rheum Dis Clin North Am 1994;20:535–59.

    PubMed  CAS  Google Scholar 

  4. Lufkin EG, Zilkoski M. Diagnosis and management of osteoporosis. American Academy of Family Physicians, Kansas City, MO: American Academy of Family Physicians, 1996. American Family Physician Monograph No. 1.

    Google Scholar 

  5. Mundy GR. Peptides and growth regulatory factors in bone. Rheum Dis Clin North Am 1994;20:577–88.

    PubMed  CAS  Google Scholar 

  6. Jackson JA, Kleerekoper M. Osteoporosis in men: diagnosis, pathophysiology, and prevention. Medicine (Baltimore) 1990; 69:137–52.

    CAS  Google Scholar 

  7. Christiansen C, editor. Proceedings of a symposium: consensus development conference on osteoporosis. Am J Med 1991;91 Suppl 5B:1S-68S.

    Article  Google Scholar 

  8. Melton LJ III, Eddy DM, Johnston CC Jr. Screening for osteoporosis. Ann Intern Med 1990;112:516–28.

    Article  PubMed  Google Scholar 

  9. Breslau NA. Calcium, estrogen, and progestin in the treatment of osteoporosis. Rheum Dis Clin North Am 1994;20: 691–716.

    PubMed  CAS  Google Scholar 

  10. Committee on Nutritional Status During Pregnancy and Lactation, Institute of Medicine, National Academy of Sciences. Nutrition during pregnancy. Washington, DC: National Academy Press, 1990:318–35.

    Google Scholar 

  11. Committee on Nutritional Status During Pregnancy and Lactation, Institute of Medicine, National Academy of Sciences. Nutrition during lactation. Washington, DC: National Academy Press, 1991:204–6.

    Google Scholar 

  12. Licata AA. Therapies for symptomatic primary osteoporosis. Geriatrics 1991;46:62–7.

    PubMed  CAS  Google Scholar 

  13. Wishart JM, Need AG, Horowitz M, et al. Effect of age on bone density and bone turnover in men. Clin Endocrinol (Oxf) 1995;42:141–6.

    Article  CAS  Google Scholar 

  14. Orwoll ES, Bliziotes M. Heterogeneity in osteoporosis. Rheum Dis Clin North Am 1994;20:671–83.

    PubMed  CAS  Google Scholar 

  15. Banas MP, Kaplan FS, Fallon MD, Haddad JG. Regional migratory osteoporosis: a case report and review of the literature. Clin Orthop 1990;250:303–9.

    PubMed  Google Scholar 

  16. Bauer RL. Assessing osteoporosis. Hosp Pract 1991;26 Suppl 1:23–9.

    Google Scholar 

  17. Bouxsein ML, Marcus R. Overview of exercise and bone mass. Rheum Dis Clin North Am 1994;20:787–99.

    PubMed  CAS  Google Scholar 

  18. Prince RL, Smith M, Dick IM, et al. Prevention of postmenopausal osteoporosis: a comparative study of exercise, calcium supplementation, and hormone-replacement therapy N Engl J Med 1991;325:1189–95.

    Article  PubMed  CAS  Google Scholar 

  19. Grisso JA, Attie M. Prevention of osteoporotic fractures. In: Lavizzo-Mourey R, Day S, Diserens D, Grisso JA, editors. Practicing prevention for the elderly. Philadelphia: Hanley & Belfus, 1989:107–23.

    Google Scholar 

  20. US Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore: Williams & Wilkins, 1996: 509–16, 829–43.

    Google Scholar 

  21. Patel U, Skingle S, Campbell GA, Crisp AJ, Boyle IT. Clinical profile of acute vertebral compression fractures in osteoporosis. Br J Rheumatol 1991;30:418–21.

    Article  PubMed  CAS  Google Scholar 

  22. Rifat SF, Kiningham RB, Peggs JF. Calcitonin in the treatment of osteoporotic bone pain. J Fam Pract 1992;35:93–6.

    PubMed  CAS  Google Scholar 

  23. Avioli LV. Calcitonin therapy in osteoporotic syndromes. Rheum Dis Clin North Am 1994;20:777–85.

    PubMed  CAS  Google Scholar 

  24. Taylor AK, Lueken SA, Libanata C, Baylin DJ. Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum Dis Clin North Am 1994;20:589–605.

    PubMed  CAS  Google Scholar 

  25. Hagiwara S, Yang S, Gluer CC, Bendavid E, Genant HK. Noninvasive bone mineral density measurement in the evaluation of osteoporosis. Rheum Dis Clin North Am 1994; 20:651–65.

    PubMed  CAS  Google Scholar 

  26. National Osteoporosis Foundation. Bone densitometry and its use in the diagnosis of osteoporosis. Osteoporosis Clin Updates 1996; l (3):l–4.

    Google Scholar 

  27. DATTA: diagnostic and therapeutic technology assessment: measurement of bone density with dual-energy x-ray absorptiometry (DEXA). JAMA 1992; 267: 286–94.

    Article  Google Scholar 

  28. Preventing and treating osteoporosis: what every woman needs to know. Older Women’s League (OWL), 666 11th Street NW, Suite 700, Washington, DC 20001,1994:1–20. Women’s Health Education Series.

    Google Scholar 

  29. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med 1995;332: 767–73.

    Article  PubMed  CAS  Google Scholar 

  30. Cummings SR, Browner WS, Ettinger B. Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry? Ann Intern Med 1990;113:565–7.

    Article  PubMed  CAS  Google Scholar 

  31. Stampfer MJ, Colditz G A. Estrogen replacement therapy and coronary artery disease: a quantitative review of the epidemiologic evidence. Prev Med 1991;20:47–63.

    Article  PubMed  CAS  Google Scholar 

  32. Rubin SM, Cummings SR. Results of bone densitometry affect women’s decisions about taking measures to prevent fractures. Ann Intern Med 1992;116:990–5.

    Article  PubMed  CAS  Google Scholar 

  33. Ryan PJ, Harrison R, Blake GM, et al. Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis. Br J Obstet Gynaecol 1992;99: 325–8.

    Article  PubMed  CAS  Google Scholar 

  34. Riggs BL, Melton LJ III. The prevention and treatment of osteoporosis. N Engl J Med 1992;327:620–7.

    Article  PubMed  CAS  Google Scholar 

  35. Optimal calcium intake. NIH consensus statement. 1994, June 6–8;12(4):l-31.

    Google Scholar 

  36. Calcium supplements. Med Lett 1989;31:101–3.

    Google Scholar 

  37. Laitinen K, Lamberg-Allardt C, Tunninen R, et al. Bone mineral density and abstention-induced changes in bone and mineral metabolism in noncirrhotic male alcoholics. Am J Med 1992;93:642–50.

    Article  PubMed  CAS  Google Scholar 

  38. Love RR, Mazess RB, Barden HS, et al. Effects of tamoxifen on bone mineral content in postmenopausal women with breast cancer. N Engl J Med 1992;326:852–6.

    Article  PubMed  CAS  Google Scholar 

  39. Ettinger B, Grady D. Maximizing the benefit of estrogen therapy for prevention of osteoporosis. Menopause 1994; 1:19–24.

    Article  Google Scholar 

  40. Watts NB. Treatment of osteoporosis with bisphosphonates. Rheum Dis Clin North Am 1994;20:717–31.

    PubMed  CAS  Google Scholar 

  41. Liberman UA, Weiss SR, Broil J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl Med 1995;333:1437–43.

    Article  CAS  Google Scholar 

  42. Wimalawansa SJ. Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study. Am J Med 1995;99:36–42.

    Article  PubMed  CAS  Google Scholar 

  43. Tilyard MW, Spears GFS, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992;326:357–62.

    Article  PubMed  CAS  Google Scholar 

  44. Bikle DD. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis. Rheum Dis Clin North Am 1994;20:759–75.

    PubMed  CAS  Google Scholar 

  45. Kimmel DB, Slovik DM, Lane NE. Current and investigational approaches for reversing established osteoporosis. Rheum Dis Clin North Am 1994;20:735–50.

    PubMed  CAS  Google Scholar 

  46. Riggs BL, Hodgson SF, O’Fallon WM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990;322:802–9.

    Article  PubMed  CAS  Google Scholar 

  47. Pak CY, Adams-Huet B, Piziak V, et al. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride: final report of a randomized controlled trial. Ann Intern Med 1995;123:401–8.

    Article  PubMed  CAS  Google Scholar 

  48. Sebert JL, Richard P, Mennecier I, et al. Monofluorophosphate increases lumbar bone density in osteopenic patients: a double-masked randomized study. Osteoporos Int 1995;5:108–14.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Louise S. Acheson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kurt C. Stange
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Family Medicine, Oregon Health Sciences University, Portland, OR, 97201, USA

    Robert B. Taylor M.D. (Professor and Chairman) (Professor and Chairman)

  2. Department of Family Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA

    Alan K. David M.D. (The Fred Lazarus, Jr., Professor and Director) (The Fred Lazarus, Jr., Professor and Director)

  3. Department of Family Medicine, St. John’s Mercy Medical Center, St. Louis, MO, 63141, USA

    Thomas A. Johnson Jr. M.D. (Chairman) (Chairman)

  4. Department of Family Medicine, University of Mississippi School of Medicine, Jackson, MS, 39216, USA

    D. Melessa Phillips M.D. (Professor and Chairman) (Professor and Chairman)

  5. Department of Family Medicine, University of California—Irvine College of Medicine, Orange, CA, 92697, USA

    Joseph E. Scherger M.D., M.P.H. (Associate Dean for Primary Care and Chair) (Associate Dean for Primary Care and Chair)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Acheson, L.S., Stange, K.C. (1998). Osteoporosis. In: Taylor, R.B., David, A.K., Johnson, T.A., Phillips, D.M., Scherger, J.E. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2947-4_122

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-2947-4_122

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-2949-8

  • Online ISBN: 978-1-4757-2947-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation